Talis Awarded NIH RADx Contract to Launch Talis One™ System for Point-of-Care COVID-19 Testing and Further Strengthens Financial Position and Leadership Team

MENLO PARK, Calif., July 31, 2020 /PRNewswire/ -- Talis Biomedical Corporation, a company dedicated to developing high-performance point-of-care diagnostic tests for infectious diseases, today announced that it has secured a $25......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Friday, 31 July

Share |